Carving new paths to improve health outcomes

There is one way to cross the divide between medical advances and actual improvements in population health: by establishing the economic and scientific value of innovative therapies to payers, healthcare professionals and patients. Precision Value & Health was created for just that purpose. We are a global group of experts, more than 500 strong, who partner with pharmaceutical and life sciences companies to ensure patient access to life-changing therapies. Together, we are carving a new path, accelerating improved health outcomes so people the world over can live longer, healthier lives.

Science savvy and patient-centric

Across the commercialization continuum, we establish scientific, economic, clinical, and humanistic value so patients can access the medicines they need.

Our comprehensive service offering encompasses science, research, technology, analytics, and communications, all tailored to today’s patient-centric landscape. Precision Value & Health is an augmentation of complementary businesses that work in concert.
Innovative health policy research and economic analysis for influencing policy debates on critical healthcare issues
Our multidisciplinary team serves as your dedicated scientific advisory panel, combining state-of-the-art research methods with insights from industry leaders, academic luminaries, and medical policymakers to tackle complex healthcare questions and deliver evidence that speaks to your audience.
Visit Site
More
Global experts in health economic value demonstration, pricing & market access, and commercialization excellence
Precision Xtract is a real-world research, health economics, and payer analytics consultancy that helps the leading pharmaceutical and life sciences companies get innovative therapies in the hands of providers and patients who need them most. Our collection of top-tier scientists, payer and pharma executives, economists, and world-respected academicians assists clients in every stage of the therapeutic commercialization process. From satisfying the increased demand for evidence of effectiveness and value to developing robust pricing and uptake models to delivering access and pull-through solutions critical to supporting market adoption.

For global pharmaceutical, life sciences, and device companies seeking to improve patient health in parallel with commercial success, Precision Xtract is here to help.

Visit Site
More
Advancing payer marketing through experiential strategy, effective value demonstration, and market access-focused resource development
The value of innovative medical treatments often begins with cost. As former payers ourselves, we know. So we identify and generate evidence of economic, clinical, and humanistic value, then analyze it to effectively demonstrate the total value of medical innovations—and maximize commercial success.
Visit Site
More
Positioning disruptive medical innovations to KOLs, providers, and patients with rigorous science, data, and messaging
Our clients change the standards of medicine. So we give them extraordinary work that changes the minds of the industry, melding strategy, creative, and technology into exceptional brand engagement platforms—clutter-busting marketing that speaks to healthcare providers and patients alike.
Visit Site
More
Interpreting and communicating the science of medicine throughout the R&D and commercial life cycle
ETHOS has established itself as an authority in understanding and translating the science of medicine, with more than 120 employees including over 40 with doctoral degrees in science. We reach and inform physicians, providers and other stakeholders through medical affairs and marketing based scientific content.
Visit Site
More

Thought leader engagement and insights

Peer-to-peer strategy and tactics

Scientific platform development

Medical curriculum development

Evidence-based health policy research

Quantifying unique sources of value

Influencing value frameworks

Measuring stakeholder preferences

Global pricing and reimbursement

Access strategy and analytics

Contracting strategy

Health economics and outcomes research

Payer value message development

Account manager resources and training

Above-brand market development

Channel strategy and management

Disease awareness

Multichannel marketing

Media and analytics

Brand strategy creative foundation

Cost and coverage pull-through solutions

Quality access analytics

Promotion response modeling

Payer, health system, and SPP data management services

The perspective to look at things from different distances to realize their true value.

Healthcare innovations are changing the treatment of acute and chronic disease. However, the swiftest course to patient access needs to be charted. We can help by leveraging the requisite expertise from every point along the continuum. The best path is not a straight line but a loop of continuous feedback and adjustments that helps realize the full value of medical innovations—throughout their life cycle.
  • Evidence-based health policy research
  • Quantifying unique sources of value
  • Influencing value frameworks
  • Measuring stakeholder preferences
  • Global pricing and reimbursement
  • Access strategy and analytics
  • Contracting strategy
  • Health economics and outcomes research
  • Cost and coverage pull-through solutions
  • Quality access analytics
  • Promotion response modeling
  • Payer, health system, and SPP data management services
  • Payer value message development
  • Account manager resources and training
  • Above-brand market development
  • Channel strategy and management
We can help you navigate the entire route to commercialization or meet you at any point along the path.
Tap the pathway to view our comprehensive and integrated capabilities
Tap the pathway to view our comprehensive and integrated capabilities
We help pharmaceutical and life sciences companies work with global payers to meet evidence requirements and substantiate value. We harness the insights of leading academics, policy makers, and payers themselves to craft messages that communicate compelling value. We build brands and educate healthcare professionals and patients about disease states and the medications that can treat them. Together, we create powerful results.
Dan Renick, RPh
President
Healthcare professional for 20+ years, holding a wealth of information on stakeholders across managed care, pharmaceutical managed markets, pharmacy provider organizations, and market access strategic consulting. Previous roles include President of Hobart Group Holdings, and executive positions at Humana and Merck, providing expert insight into various segments and channels of managed markets.
phone-icon 212.686.2650
More
Kelly Wilder
Executive Vice President and Managing Partner Integrated Market Access
An expert in integrated market access, specializing in managed markets strategy, value demonstration, and organizational leadership. Deep experience with oncology products and a keen understanding of payers, plan sponsors, and the increasing complexity in the reimbursement marketplace.
phone-icon 212.686.2650
More
Carlos Delucca
Executive Vice President and Managing Partner Integrated Market Access
Strategic visionary across managed markets, executing on planning and marketing for key payer channels. Expert in bringing new products to market with direct experience across more than 30 launches. Authority at contracting for managed care organizations, pharmacy benefits, providers, and institutions.
phone-icon 908.470.1780
More
J. Bruce Leavitt, MBA
Executive Vice President and Managing Partner
Innovator of novel promotional effectiveness measures, insight-driven analysis methodologies, and dynamic CRM-based tools and applications for account management and pull-through. Expert in solving market access challenges for pharma across market channels, therapeutic classes, and routes of administration.
phone-icon 203.487.5240
More
Larry Blandford, PharmD
Executive Vice President and Managing Partner
Industry leader in market insights, medication management, and access strategy for pharmaceuticals. Combines deep payer experience and insights across the market access landscape to drive strategic planning and guide execution.
phone-icon 908.470.1780
More
Carolyn Harley, PhD
Senior Vice President and General Manager Precision Health Economics
Established leader in the field of health economics dedicated to driving effective, efficient client services. Heads a team of economists, academic luminaries, statisticians, modelers and research scientists. Additional expertise in market access and reimbursement, public health and social services. Frequent author of published articles, presentations, and posters.
phone-icon 310.984.7756
More
Ross Maclean, MD, PhD
Senior Vice President, Head of Medical Affairs
Global expert in health services and outcomes research, health economics, health system design, health policy, and market access, with deep knowledge of HEOR for cardiovascular, metabolic and immunology products and medical affairs within a biopharma setting. Contributor to more than 70 articles appearing in peer-reviewed journals such as Archives of Internal Medicine, The American Journal of Managed Care, Journal of Medical Economics, and Health Affairs
phone-icon 310.982.6310
More
Carolyn Morgan
President, precisioneffect
Award-winning advertising expert who is noted for generating inspirational strategies and creative campaigns that exceed client expectations and drive demand. Deep understanding of life sciences and pharmaceuticals, medical devices, and diagnostics that help her lead a team of exceptional healthcare marketers.
phone-icon 617.725.3273
More
Precision Leaders Featured in Harvard Business Review: Making Lifesaving Medical Treatments More Affordable
October 25, 2019—Recent years have brought significant innovation in potentially curative therapies for several diseases. To expedite patient access to these therapies, the US Food and Drug Administration (FDA) has undertaken progressive efforts to accelerate drug approval. For example, the FDA’s Breakthrough Therapy Program, enacted in 2012, has approved nearly 140 breakthrough therapies and shortened novel drug approval times by almost a year. Read more
CONTACT US
Learn precisely what Precision can do for you.
We look forward to explaining our methods, learning about your needs, and exploring ways to work together. For information and inquiries please contact:
DAN RENICK
President
phone-icon 908.470.1780

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.